{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:15:17Z","timestamp":1789215317063,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ahj.2005.03.032","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T07:14:42Z","timestamp":1131693282000},"page":"919.e1-919.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction"],"prefix":"10.1016","volume":"150","author":[{"given":"Pietro","family":"Di Pasquale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Scalzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspare","family":"Parrinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Fasullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giambanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Fatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Paterna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.03.032_bib1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","article-title":"Pathological hypertrophy and cardiac interstitium fibrosis and renin angiotensin aldosterone system","volume":"83","author":"Weber","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.032_bib2","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/0002-9149(93)90238-8","article-title":"Aldosterone and antialdosterone therapy in congestive heart failure","volume":"71","author":"Weber","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.03.032_bib3","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","article-title":"Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension","volume":"71","author":"Brilla","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.03.032_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(96)88542-7","article-title":"Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone and aldosterone antagonist","volume":"29","author":"Van Belle","year":"1995","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ahj.2005.03.032_bib5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1552-4604.1993.tb03901.x","article-title":"Evidence of partial escape of renin angiotensin aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors","volume":"33","author":"Borghi","year":"1993","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.032_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1071-9164(96)80009-1","article-title":"Aldosterone escape during angiotensin converting enzyme inhibitor therapy in chronic heart failure","volume":"2","author":"Struthers","year":"1996","journal-title":"J Card Fail"},{"key":"10.1016\/j.ahj.2005.03.032_bib7","first-page":"643","article-title":"A. Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study","volume":"125","author":"Rodriguez","year":"1997","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.ahj.2005.03.032_bib8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.032_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1012754514127","article-title":"ACE-inhibition plus mineralocorticoid antagonism versus ACE-inhibition alone in patients with anterior myocardial infarction","volume":"15","author":"Di Pasquale","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ahj.2005.03.032_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-5273(00)00425-3","article-title":"The combination ace-inhibitors plus canrenoate in patients with anterior myocardial infarction: safety and tolerability study","volume":"77","author":"Di Pasquale","year":"2001","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2005.03.032_bib11","first-page":"121","article-title":"Additional beneficial effects of canrenoate in patients with anterior myocardial infarction on ACE-inhibitor treatment. A pilot study","volume":"2","author":"Di Pasquale","year":"2001","journal-title":"Ital Heart J"},{"key":"10.1016\/j.ahj.2005.03.032_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantification of left ventricle by two-dimensional echocardiography","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2005.03.032_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0894-7317(97)70062-2","article-title":"The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography","volume":"10","author":"Oh","year":"1997","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.ahj.2005.03.032_bib14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.032_bib15","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.032_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","article-title":"Rise in plasma concentration of aldosterone during long-term angiotensin II suppression","volume":"91","author":"Staessen","year":"1981","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ahj.2005.03.032_bib17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/00005344-198211000-00014","article-title":"Antihypertensive therapy with MK 421: angiotensin II\u2013renin relationship to evaluate efficacy of converting enzyme blockade","volume":"4","author":"Biolaz","year":"1982","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2005.03.032_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00877755","article-title":"Escape of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy","volume":"9","author":"Pitt","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ahj.2005.03.032_bib19","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin converting enzyme inhibitor and loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study (RALES)","volume":"78","author":"The RALES Investigators","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.03.032_bib20","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2005.03.032_bib21","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/euhj.1998.1099","article-title":"Inverse relationship between aldosterone and artery compliance in chronically treated heart failure patients","volume":"19","author":"Duprez","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.03.032_bib22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","article-title":"Effects of adding spirolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease","volume":"76","author":"Barr","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.03.032_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(93)91332-M","article-title":"Neurosteroid biosynthesis: gene for adrenal for steroidogenic enzymes are expressed in the brain","volume":"629","author":"Mellon","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.ahj.2005.03.032_bib24","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","article-title":"Vascular aldosterone. Biosynthesis and a link to angiotensin II induced hypertrophy of vascular smooth muscle cells","volume":"269","author":"Hatakeyama","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ahj.2005.03.032_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/joe.0.0430315","article-title":"Similarity between a substance produced by the heart in vitro and the 18-monoacetyl derivative of d-aldosterone","volume":"43","author":"Knox","year":"1969","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ahj.2005.03.032_bib26","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in rat. Physiological regulation","volume":"273","author":"Sivestre","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ahj.2005.03.032_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/jmcc.1996.0072","article-title":"High affinity NAD(+)-dependent 11 beta-hydroxysteroid dehydrogenase in the human heart","volume":"28","author":"Slight","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ahj.2005.03.032_bib28","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.RES.81.5.857","article-title":"Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of the nephrectomized rats","volume":"81","author":"Volpe","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2005.03.032_bib29","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"Activation of cardiac aldosterone production in rat myocardial infarction","volume":"99","author":"Sivestre","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.03.032_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199909023411009","article-title":"Aldosterone and spironolactone in heart failure","volume":"341","author":"Weber","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.03.032_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejheart.2003.07.009","article-title":"Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects","volume":"6","author":"Di Pasquale","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2005.03.032_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14017430410026746","article-title":"Relationship between ACE-DD polymorphism and diastolic performance in healthy subjects","volume":"38","author":"Di Pasquale","year":"2004","journal-title":"Scand Cardiovasc J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305003315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305003315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:18:12Z","timestamp":1757567892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870305003315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0002870305003315"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.03.032","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.03.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}